Navigation Links
Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine
Date:1/8/2008

WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- The Academic Alliance Foundation announces the publishing of Global HIV/AIDS Medicine, the first medical textbook aimed at a comprehensive approach to the management of HIV/AIDS as a global problem. The book reflects a changing landscape in HIV/AIDS prevention, diagnosis, and treatment, with particular emphasis on the realities of HIV/AIDS in resource limited settings.

"On behalf of each of the editors, we hope this textbook is of great value to clinicians, scientists, and epidemiologists throughout the world who are involved in the battle against HIV/AIDS," said Dr. Warner Greene, President of the Academic Alliance Foundation.

By bringing in new global expertise and explicitly addressing the challenges of prevention and care in diverse resource limited settings, Global HIV/AIDS reflects growing recognition of the need to train medical professionals to treat the epidemic on the stage on which it often unfolds. The book features: current guidance and realities of HIV/AIDS management by geographical region; the ability to diagnose AIDS manifestations by comparing them to full-color clinical images; and tables that allow a practitioner to quickly gather, compare and review essential data.

"Extremely readable and compact, yet thorough enough to answer most questions clinicians might encounter in their daily struggle to provide optimal care to patients with HIV infections." (Journal of the American Medical Association)

Collectively, the background and experience of the editors is nothing short of outstanding, a "who's who" of global experts on HIV and AIDS medicine. Warner C. Greene, M.D., PhD, a world-renowned scientist and expert in the field of virology and immunology, is the founding director and senior investigator of the Gladstone Institute of Virology & Immunology and professor of medicine, microbiology and immunology at the University of California. Dr. Greene is also a found
'/>"/>

SOURCE Academic Alliance Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Academic Researcher of the Year 2007
2. Clinical Trials Directive still hampering academic medical research
3. Association of Academic Health Centers Names University of Pennsylvanias Dr. Arthur H. Rubenstein Chairman of the Board of Directors
4. New Academic Analysis Identifies Three Barriers to Achieving Healthy and Achievable Policies to Combat Obesity in America
5. PDSS reliable in measuring impact of sleep disorders on teens academic performance
6. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
7. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
8. Lung Cancer Alliance Stands Behind CT Screening for Lung Cancer
9. SMART Association Becomes Healthcare Council Member of Smart Card Alliance
10. Video and Photo: Leading CEOs Launch Alliance With American Red Cross to Strengthen Nations Preparedness for Disasters
11. Statement from the Alliance for Quality Nursing Home Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...fer Tips for Finding Quality Care , ARLINGTON H...onsumers looking to cut costs during the economic ...f care, warns the American Society of Plastic Surg...ubstitute fillers for facelifts, ASPS says the wor...ofessional training. This concern was discussed re...
(Date:11/20/2008)...0 Want to lower your risk for type... minutes of physical activity,three times a day. ...,s what,the U.S. Centers for Disease Control and ... pressure, manage your cholesterol and lose weight... people have diabetes, and heart,disease is the l...
(Date:11/20/2008)...0 Kaiser Permanente is the only,h...tar ratings in the 2009,Edition Healthcare Qualit...atient Advocate (OPA). , The report card re... show,Kaiser Permanente Northern California and S...verall in clinical quality among the nine health p...
(Date:11/20/2008)...nia, San Diego Health Sciences leaders have announ... Understanding (MOU) with Johnson & Johnson Pharma...with the objective of developing future collaborat...ce human health. , The MOU establishes a framew...en the UC San Diego School of Medicine, Skaggs Sch...
Breaking Medicine News(10 mins):Health News:Caution Urged as Patients Seek Deals on Cosmetic Surgery 2Health News:10 Minutes at a Time: Simple Steps to Get Moving and Reduce Your Risk of Diabetes and Heart Disease 2Health News:Kaiser Permanente Receives the Most Stars in California Office of Patient Advocate's Annual Quality Report Card 2Health News:Kaiser Permanente Receives the Most Stars in California Office of Patient Advocate's Annual Quality Report Card 3Health News:UC San Diego announces collaboration with Johnson & Johnson Pharmaceutical Research & Development 2
...hopedic surgeon on the medical staff at Baylor Med...es will be a normal occurrence as the soccer// and...ill now be stocking up on ice packs, heating pads ...at their little champions are in as little discomf...
...ght not enter the Guinness Book of World Records, ...ass 12 exam at the age// of 11 definitely makes he...daughter of Dhanpat Singh Saini, a medical practit... science stream as a regular student of Mangalam V...
... of Medical Sciences (RIMS) is organising a three-...s from the northeastern states from today// the 11...aim of making up for the shortfall of sports medic...North Eastern Council is sponsoring the course. P...
... about the ill effects of coffee, coffee drinkers ... has shown that people// who drink one to three cu...ome extent. This research was part of the Iowa Wom... to 60 per cent of antioxidants which help in the ...
Other Medicine News:Health News:Expect Aching Muscles And Joints This Sports Season 2Health News:Jaipur Girl’s Rare Feat: The Youngest To Pass Class 12 At The Age Of 1 2
(Date:11/20/2008)...-USNewswire/ -- The following is being released by... WHAT: World AIDS Day Audio Media Conference ,..., 11:00 a.m. EST , Call-in number: 1-800-949...eadytalk.com/r/1xe41i2yre8rs , , WHY: Wi...le newly put on treatment worldwide, advocates are...
(Date:11/20/2008)...S OF FIRST PHASE III TRIAL SHOW SIGNIFICANT, ...DAILY FUNCTION, IN, FI...BRUSSELS, Belgium, Nov. 20 /PRNewswire-FirstCall/,...nd UCB (Euronext Brussels: UCB),announced today p...t of two,Phase III pivotal clinical trials of sod...
(Date:11/20/2008)...Newswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: B...rom the Phase 1B,clinical trial of their lead dru..., BZL101, at the Society for Integrative Oncology,...gia. The Company,s oral presentation was selected...as a part of the Best of the,SIO Session on Novem...
(Date:11/20/2008)...-- Clinical data from a prospective,registry pres... shows DVT,treatment with the Trellis(R) Peripher...anta Clara, CA) successfully breaks up the blood c... This technique, called isolated pharmacomechanic... and safely than current catheter-directed thrombo...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Canadian Society of Exercise Physiology Annual Scientific Conference 1170 1Canadian Society of Exercise Physiology Annual Scientific Conference 1170 2Researchers successfully simulate photosynthesis and design a better leaf 1169 1Researchers successfully simulate photosynthesis and design a better leaf 1169 2Researchers successfully simulate photosynthesis and design a better leaf 1169 3Research highlights important indicators of early stage ovarian cancer 5988 1Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 1Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 2Abbott Donates Cool Globe to Lake County Forest Preserves for Permanent Display at Greenbelt Cultural Center 5986 3
... - Pluristem Life Systems,Inc. (OTCBB:PLRS) (DAX:...commercialization of products for a variety of mal...announced today that,Pluristem,s PLacenta eXpanded...ve properties that the Company believes gives thes... (PD). PLX cells,are Pluristem,s placental-derived...
...vement in Signs and,Symptoms Of Moderate to Severe...chieving Disease Remission at One-Year,Mark , BA... show nearly,75 percent of patients with moderate ...mumab (CNTO 148) and methotrexate (MTX),experience...n,arthritis symptoms (ACR 20). This was according ...
Other Medicine Technology:Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 2Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 3Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's,Disease 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 2Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 3Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 4Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid,Arthritis Study 5
The Phoresis is a state-of-the-art digital imaging system which allows scanning and storage of electrophoresis results from any Sebia gel including immunofixation. This system provides benefits to an
LapEvac, designed for use during laparoscopic surgery, will help reduce many of the risks associated with poor vision and loss of distension due to smoke & efforts to clear smoke and aerosols from th
Inquire
Inquire
Medicine Products: